Tau‐negative AD patients did not show significantly more WMHs, infarcts, or alpha‐synuclein pathology compared to tau‐PET‐positive AD patients, lowering the probability of Aβ‐positive tau‐PET‐negative dementia patients being on a non‐AD trajectory. This evidence concerns the gene MAPT and Alzheimer disease.